Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

Articles

Report reveals growing divide between subsidized and unsubsidized enrollees.



ACA Enrollees Share Mixed Opinions Ahead of Open Enrollment, Upcoming Election

Patients with transfusion-dependent β-thalassemia experienced 14.8 hospitalizations annually, according to the findings.

High Health Care Burden of Transfusion-Dependent β-Thalassemia

 in 2023, where she produces written content covering multiple disease states.

She has a BA in journalism from Seton Hall University. You can connect with Brooke on 

Despite proven benefits, referrals to pulmonary rehabilitation and palliative care for patients with idiopathic pulmonary fibrosis (IPF) in England remain significantly lower than for other respiratory conditions.

Low Pulmonary Rehabilitation, Palliative Care Referrals for Patients With IPF Persist

The machine learning model shows promise in detecting paroxysmal nocturnal hemoglobinuria (PNH) by assessing electronic health records (EHR) data, potentially transforming the diagnostic landscape for rare diseases.

New AI Tool Identifies Undiagnosed PNH in Health Records

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Hematology

Hepatology

Immunology

Infectious Disease

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Guidelines

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

View

This clinical brief provides a background on IDA and reviews the use of IV treatment for iron repletion.

Iron deficiency anemia (IDA) is a prevalent condition that can significantly impact patient health. Intravenous (IV) iron therapy has emerged as an effective treatment option for iron repletion, particularly in cases where oral iron supplements are insufficient or poorly tolerated. IV iron offers rapid replenishment of iron stores and improvement in hemoglobin levels. The choice of IV iron formulation and dosing regimen should be tailored to the individual patient's needs, considering factors such as severity of anemia, comorbidities, and potential adverse effects.

Managing Iron Deficiency Anemia With IV Iron Therapy to Optimize Outcomes in Patient-Centered Care

Supplements and Featured Publications